|
NUDT21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.73250000404346E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.08459999659649E-08 |
| Normal-vs-Stage2 |
8.26900000000519E-05 |
| Normal-vs-Stage3 |
1.1918999998084E-07 |
| Normal-vs-Stage4 |
3.01849999995163E-07 |
| Stage1-vs-Stage2 |
8.405600E-01 |
| Stage1-vs-Stage3 |
3.868000E-01 |
| Stage1-vs-Stage4 |
2.931200E-01 |
| Stage2-vs-Stage3 |
7.014400E-01 |
| Stage2-vs-Stage4 |
5.155800E-01 |
| Stage3-vs-Stage4 |
7.291600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.13919995448475E-09 |
| Normal-vs-AfricanAmerican |
7.677700E-03 |
| Normal-vs-Asian |
5.54209999999999E-05 |
| Caucasian-vs-AfricanAmerican |
3.985000E-01 |
| Caucasian-vs-Asian |
8.347400E-01 |
| AfricanAmerican-vs-Asian |
5.474600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.73920014343321E-10 |
| Normal-vs-Female |
7.92009999805998E-08 |
| Male-vs-Female |
5.750300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.11039999995644E-07 |
| Normal-vs-Age(41-60Yrs) |
3.94000000403238E-08 |
| Normal-vs-Age(61-80Yrs) |
1.00900000021831E-07 |
| Normal-vs-Age(81-100Yrs) |
1.401630E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.450400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.712200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.661800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.295400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.126000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.000200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.485200E-01 |
| Classical-VS-Follicular |
3.211300E-04 |
| Classical-VS-Other |
2.038200E-01 |
| Classical-VS-Normal |
1.03969999998288E-06 |
| Tall-VS-Follicular |
2.094200E-01 |
| Tall-VS-Other |
4.322600E-01 |
| Tall-VS-Normal |
1.806240E-04 |
| Follicular-VS-Other |
9.672200E-01 |
| Follicular-VS-Normal |
3.51009998844631E-09 |
| Other-VS-Normal |
6.975300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26019999990845E-08 |
| Normal-vs-N1 |
1.47269999972721E-07 |
| N0-vs-N1 |
3.773800E-01 |
|
|
